Table 5.

Factors Associated With Hazard of Death and Survival Time in Stages I to IIIA NSCLC Patients^a,b.

	HR	Estimate (SE)	Value (error)	P
Total number of patients n = 275
Age, median (IQR), years	1.02	0.03 (0.02)	−0.02 (0.02)	.27
Gender
Female	Ref
Male	1.46	0.37 (0.34)	−0.30 (0.28)	.28
UICC stage
I	Ref
II	1.07	0.07(0.47)	−0.05 (0.37)	.88
IIIA	1.53	0.42 (0.46)	−0.34 (0.37)	.36
Add-on VA therapy
No	Ref
Yes	1.00	0.007 (0.38)	−0.005 (0.30)	.99
Cancer-directed surgery
No	Ref
Yes	0.22	−1.49 (0.43)	1.20 (0.30)	<.001***
Radiation lung
No	Ref
Yes	1.17	0.15 (0.40)	−0.12 (0.32)	.70
CTx first
No	Ref
Yes	0.83	−0.19 (0.37)	0.15 (0.30)	.61

Abbreviations: NSCLC, non–small cell lung cancer; HR, hazard ratio; SE, standard error; IQR, interquartile range; Ref, reference; UICC, Union for International Cancer Control; VA, Viscum album L; CTx, chemotherapy.

^aMultivariate regression analysis, HR based on Weibull model; model for each group adjusted for demographic variables and treatment regimens.

^bExcept age being a continuous variable all other explanatory variables were of categorical nature.

^***P ≤ .001.